Bryleos Competitors and Similar CompaniesClear all
Bryleos's competitors and similar companies include Ajinomoto Bio-Pharma Services, Pfizer, Novartis and Hutchison China Meditech.
 Ajinomoto Bio-Pharma Services Ajinomoto Bio-Pharma Services (formerly known as Ajinomoto Althea) is a contract development and manufacturing organization (CDMO). |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Hutchison China Meditech Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products. | ||
Founding Date | Founding Date 2021 | Founding Date 1998 | Founding Date 1849 | Founding Date 1996 | Founding Date 2000 |
Type | Type Private | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Johnson City, US HQ | Locations San Diego, US HQ Wetteren, BE Visakhapatnam, IN Osaka, JP | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Shanghai, CN HQ Beijing, CN Jiangsu, CN Shanghai, CN Shanghai, CN Hong Kong, HK Hong Kong, HK see more |
Employees | Employees 7 | Employees 68610% decrease | Employees 81,0008% decrease | Employees 75,883 | Employees 1,811 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 163.9 b | Valuation ($) N/A | Valuation ($) 3.6 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $548.5m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $16.1b (FY, 2025) | Cost of goods $8.4b (FY, 2025) | Cost of goods $324.4m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $46.5b (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit $224.2m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income $7.8b (FY, 2025) | Net income $14b (FY, 2025) | Net income $435.1m (FY, 2025) |
Operating ⚠ | |||||
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 32 (FY, 2024) | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products N/A |
Registration Phase Products | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products 5 (FY, 2024) | Registration Phase Products 8 (FY, 2022) | Registration Phase Products N/A |
Funding | |||||
Total funding raised | Total funding raised $ 5m | Total funding raised $ 3.5m | Total funding raised N/A | Total funding raised $ 6.5m | Total funding raised $ 100m |
For sources of this data, please see the company profile
View Company Profiles
Ajinomoto Bio-Pharma Services
HQ
San Diego, US
Ajinomoto Bio-Pharma Services (formerly known as Ajinomoto Althea) is a contract development and manufacturing organization (CDMO).
View companyPfizer
HQ
New York, US
Employees
81,000↓ 8% decrease
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View companyNovartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyHutchison China Meditech
HQ
Shanghai, CN
Employees
1,811
Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products.
View company